MBExC - Cluster of Excellence Multiscale Bioimaging Revenue and Competitors
Estimated Revenue & Valuation
- MBExC - Cluster of Excellence Multiscale Bioimaging's estimated annual revenue is currently $153k per year.
- MBExC - Cluster of Excellence Multiscale Bioimaging's estimated revenue per employee is $51,000
Employee Data
- MBExC - Cluster of Excellence Multiscale Bioimaging has 3 Employees.
- MBExC - Cluster of Excellence Multiscale Bioimaging grew their employee count by 0% last year.
MBExC - Cluster of Excellence Multiscale Bioimaging's People
Name | Title | Email/Phone |
---|
MBExC - Cluster of Excellence Multiscale Bioimaging Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 6 | 0% | N/A | N/A |
#2 | $33.1M | 295 | 0% | N/A | N/A |
#3 | $10.4M | 102 | -2% | N/A | N/A |
#4 | $5.9M | 64 | 19% | N/A | N/A |
#5 | $16.6M | 148 | 24% | N/A | N/A |
#6 | $43.5M | 341 | 13% | N/A | N/A |
#7 | $52.1M | 409 | 7% | N/A | N/A |
#8 | $3.3M | 40 | N/A | N/A | N/A |
#9 | $1M | 16 | N/A | N/A | N/A |
#10 | $5.1M | 56 | N/A | N/A | N/A |
What Is MBExC - Cluster of Excellence Multiscale Bioimaging?
The goal of the MBExC is to decipher disease relevant nanoscale functional units in the heart and the brain by using a multiscale approach. This integrates research on nanoscale units with analyses of excitable cell networks by using state-of-the-art bioimaging techniques. Together with an interdisciplinary research network across the Göttingen Campus, we provide unique insights into both cardiac and neural networks and develop innovative therapeutic strategies for disorders affecting the heart, the brain, or both.
keywords:N/AN/A
Total Funding
3
Number of Employees
$153k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 25 | 127% | N/A |
#2 | $7.5M | 28 | 22% | N/A |
#3 | N/A | 71 | 42% | N/A |
#4 | $54.6M | 301 | 9% | N/A |